Proteasomal function is impaired in substantia nigra in Parkinson's disease

被引:549
作者
McNaught, KSP [1 ]
Jenner, P [1 ]
机构
[1] Guys Kings & St Thomas Sch Biomed Sci, Div Pharmacol & Therapeut, Neurodegenerat Dis Res Ctr, London SE1 1UL, England
关键词
Parkinson's disease; alpha-synuclein; Lewy body inclusion; proteasome; ubiquitin; ubiquitin carboxy-terminal hydrolase L1;
D O I
10.1016/S0304-3940(00)01701-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The accumulation of alpha -synuclein, ubiquitin and other proteins in Lewy bodies in degenerating dopaminergic neurones in substantia nigra in idiopathic Parkinson's disease (PD) suggest that inhibition of normal/abnormal protein degradation may contribute to neuronal death. We now show for the first time that the chymotrypsin- (39%), trypsin- (42%) and postacidic-like (33%) hydrolysing activities of 20/26S proteasome are impaired in substantia nigra in PD. Proteasome inhibition does not appear to result from drug treatment since high concentrations of L-3,4-dihydroxyphenylalanine had no effect on enzymatic activity in vitro. These observations provide the first direct evidence that inhibition of the ubiquitin-proteasome pathway leading to altered protein handling and Lewy body formation may be responsible for degeneration of the nigrostriatal pathway in idiopathic PD. (C) 2001 Published by Elsevier Science Ireland Ltd.
引用
收藏
页码:191 / 194
页数:4
相关论文
共 20 条
[1]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[2]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[3]   Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis [J].
Canu, N ;
Barbato, C ;
Ciotti, MT ;
Serafino, A ;
Dus, L ;
Calissano, P .
JOURNAL OF NEUROSCIENCE, 2000, 20 (02) :589-599
[4]   Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation [J].
Craiu, A ;
Gaczynska, M ;
Akopian, T ;
Gramm, CF ;
Fenteany, G ;
Goldberg, AL ;
Rock, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :13437-13445
[5]   Neuropathology of Parkinson's disease [J].
Forno, LS .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) :259-272
[6]   Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man [J].
Gerlach, M ;
Riederer, P .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) :987-1041
[7]   Impaired clearance of oxidised proteins in neurodegenerative diseases [J].
Halliwell, B ;
Jenner, P .
LANCET, 1998, 351 (9114) :1510-1510
[8]   Understanding cell death in Parkinson's disease [J].
Jenner, P ;
Olanow, CW .
ANNALS OF NEUROLOGY, 1998, 44 (03) :S72-S84
[9]   Impaired proteasome function in Alzheimer's disease [J].
Keller, JN ;
Hanni, KB ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (01) :436-439
[10]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108